Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 07, 2015 12:15 AM ET

Capital Markets

Company Overview of Venrock

Company Overview

Venrock is a venture capital and private equity firm specializing in seed, early stage, late-stage, mezzanine, growth capital, and first round investments. The firm may also consider second round investments. It primarily invests in information technology, healthcare, media, and energy and nanotechnology, agtech, biofuels, specialty pharmaceuticals, animal health, biotechnology, drug discovery and development, life sciences, material sciences, digital media and mobile, Internet, Ad Tech, Generics, consumer and consumer health, consumer technology and electronics, enablers, healthcare information technology and services, diagnostics, medical devices, cloud-centric technologies, crowd, fintech...

530 Fifth Avenue

22nd Floor

New York, NY 10036

United States

Founded in 1969





Key Executives for Venrock

Partner and General Partner
Age: 48
Partner Emeritus
Age: 58
Partner and General Partner
Age: 48
Age: 74
Compensation as of Fiscal Year 2015.

Venrock Key Developments

Mevion Medical Systems, HOPU Investments, YuanMing Capital, Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners Forms Joint Venture to Produce, Sell and Service Proton Therapy Systems for the Chinese Market

Mevion Medical Systems announced that it has entered into an investment agreement where up to $200 million will be invested in Mevion to accelerate its worldwide expansion. The investment was led by HOPU Investments, YuanMing Capital, and participated in by other Chinese investors and existing U.S. investors Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners. Concurrent with the investment, Mevion and the lead investors will form a joint venture in China to produce, sell and service proton therapy systems for the Chinese market. HOPU and YuanMing have extensive experience investing in successful healthcare companies and offer a significant network of healthcare experience in China.

Venrock Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 through Nov-13-2014

Venrock Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 through Nov-13-2014. Venue: Apella, 450 East 29th Street, New York, New York, United States. Presentation Date & Speakers: Nov-12-2014, Camille D. Samuels, Partner. Nov-13-2014, Camille D. Samuels, Partner.

Venrock Announces Executive Appointments

Venrock announced that Camille Samuels and Doug Dooley have joined the investment team, both in the Palo Alto office. As a Partner, Samuels brings over a decade of venture investing experience to Venrock and will continue her efforts in biotech and consumer health, while expanding her focus to later stage healthcare companies. Formerly an entrepreneur, Dooley will focus on infrastructure technologies and cloud-centric software. Previously, Samuels was a Managing Director at Versant Ventures where she invested in Achaogen (AKAO), Kythera (KYTH), and Novacardia (acquired by Merck), among others. Prior to Versant, she was responsible for business development at Tularik Inc. (acquired by Amgen) and also spent time at Genzyme, Millennium Predictive Medicine and LEK Consulting. Dooley builds on a two-decade career at infrastructure technology companies ranging from large corporations like Cisco and Intel to security and virtualization startups like Neoteris, NetScreen, and RingCube.

Similar Private Companies By Industry

Company Name Region
Evolution Media Capital, LLC United States
AFS Investments, Inc. United States
Deutsche Bank Capital Funding Trust IX United States
Emerging Markets Finance International, LLC United States
Denver Businesses United States

Recent Private Companies Transactions

Private Placement
October 5, 2015
Private Placement
September 9, 2015
Narvii Inc.
Private Placement
September 3, 2015
Kyruus, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Venrock, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at